Biphasic insulin, basal insulin and glucagon-like peptide 1 analogs control blood glucose levels in people with type 2 diabetes, but GLP-1 analogs also encourage weight loss without raising the risk of hypoglycemia, a meta-analysis found. The results were published in Diabetes, Obesity and Metabolism.
GLP-1 analogs are more beneficial for type 2 diabetes
SmartBrief Job Listings for Health Care
|Sr. Regulatory Specialist, Biotech Center of Expertise||
BASF, The Chemical Co.
|San Diego, CA|
|Director of Clinical Research||
Regenesis Biomedical, Inc.
Meridian Health Plan
|Assistant Vice President - Dental Director||